Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trialsFanyue Meng, Fengcai Zhu, Fan Gao et al.|Signal Transduction and Targeted Therapy|2021Cited by 36
B.1.351 SARS-CoV-2 Variant Exhibits Higher Virulence but Less Viral Shedding than That of the Ancestral Strain in Young Nonhuman PrimatesYu Bai, Miao Xu, Qian He et al.|Microbiology Spectrum|2022Cited by 10
The impact of bright light therapy on Parkinson's disease: A pilot study using vestibular-evoked myogenic potentialsWei-Ye Xie, Chunfeng Liu, Fen Wang et al.|Parkinsonism & Related Disorders|2025Cited by 2
Additional file 6: Table S5. of Identification of conserved and novel microRNAs in Porphyridium purpureum via deep sequencing and bioinformaticsFan Gao, Shulian Xie, Junping Lv et al.|Figshare|2016Cited by 0